Brief: Vallon Pharmaceuticals Announces Stockholder Approval Of Merger With Gri Bio And Reverse Stock Split

April 20 (Reuters) - Vallon Pharmaceuticals Inc
 VLON.O :
    * VALLON PHARMACEUTICALS ANNOUNCES STOCKHOLDER APPROVAL OF
MERGER
WITH GRI BIO, INC. AND REVERSE STOCK SPLIT
    * VALLON'S BOARD OF DIRECTORS HAS SET REVERSE SPLIT RATIO AT
1-FOR-30

Source text for Eikon:  ID:nGNX801F8Q 
Further company coverage:  VLON.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on GRI Bio

See all news